Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

China approves first domestically produced nine-valent HPV vaccine

Xinhua | Updated: 2025-05-30 16:14
Share
Share - WeChat

XIAMEN -- China approved its first domestically developed nine-valent human papillomavirus (HPV) vaccine on Thursday, according to the National Medical Products Administration.

The vaccine, Cecolin 9, was jointly developed by the Xiang An Biomedicine Laboratory, Xiamen University and Wantai BioPharm. Its approval makes China the second country in the world — after the United States — with the capability to independently supply high-valency HPV vaccines.

Since 2019, the vaccine has been through five clinical trials conducted across China, involving more than 11,000 healthy volunteers aged nine to 45.

Results from these trials showed that the vaccine provides strong protection against HPV types 16 and 18 — the same strains covered by the two-valent vaccine — as well as five other HPV types 31, 33, 45, 52 and 58, with a protection rate of over 98 percent against persistent infections lasting more than 12 months and a 100 percent protection rate against cervical infections.

For girls aged nine to 17, just two doses are sufficient to produce an immune response comparable to that seen in women aged 18 to 26 who receive three doses. For girls aged 15 to 17, it is currently the only two-dose HPV vaccine available in China.

A comparative study showed that the new vaccine offers immune responses comparable with similar international products for at least 30 months after full immunization. These findings have been published in The Lancet Infectious Diseases.

The new vaccine is the latest achievement from the research team that also developed China's first domestically made two-valent HPV vaccine in 2019. In 2021, the two-valent HPV vaccine received prequalification from the World Health Organization (WHO) and has since entered the markets of 21 countries.

Cervical cancer was the fourth most common cancer among women worldwide in 2022, according to the WHO. China made free HPV vaccination accessible to approximately 40 percent of girls aged 13 to 14 in 2024, as part of its ongoing work to tackle cervical cancer, according to the National Health Commission.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 晓雪老师下面好紧好湿| 精品福利一区二区免费视频| 天天操狠狠操夜夜操| 久久精品国产99久久无毒不卡| 特级aaa毛片| 国产一级片网址| 色吧首页dvd| 女人张腿让男桶免费视频大全| 久久精品国产精品亚洲毛片| 波多野结衣无内裤护士| 四虎4hu永久在线观看| 免费成人激情视频| 在线观看星空传媒入口| 中文字幕视频网| 杨幂精品国产福利在线| 亚洲精品成人a在线观看| 老司机67194精品线观看| 国产日韩在线视频| 91高清免费国产自产拍2021| 强制邻居侵犯456在线观看| 久久国产精品二区99| 欧美成a人片在线观看久| 免费又黄又爽又猛的毛片| 色综合小说天天综合网| 国产福利一区二区三区在线视频| a亚洲Va欧美va国产综合| 扒开两腿中间缝流白浆在线看| 五月婷婷综合在线| 欧美精品高清在线观看| 军人野外吮她的花蒂无码视频 | 无码毛片视频一区二区本码| 亚洲乱码中文字幕小综合| 清纯校花被色老头糟蹋| 又大又粗好舒服好爽视频| 韩国男男腐啪GV肉视频| 国产第一区二区三区在线观看| 999影院成人在线影院| 好爽好多水小荡货护士视频| 中文字幕在线视频观看| 日本肉漫在线观看| 乱岳合集500篇|